Immediate Impact
52 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
2023 Standout
Works of Fernando Gaion being referenced
The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Fernando Gaion | 405 | 141 | 32 | 196 | 11 | 533 | |
| E.W. Muller | 387 | 130 | 50 | 161 | 19 | 535 | |
| J.-L. Lagrange | 362 | 224 | 72 | 141 | 15 | 578 | |
| J Longueville | 279 | 147 | 25 | 132 | 20 | 619 | |
| Devron R. Shah | 231 | 182 | 39 | 186 | 7 | 580 | |
| Dominique Cazals | 245 | 67 | 142 | 136 | 11 | 515 | |
| Oyewale O. Abidoye | 447 | 220 | 35 | 142 | 24 | 648 | |
| K. Komuta | 284 | 220 | 35 | 96 | 19 | 564 | |
| Suzanne M. Fields | 380 | 140 | 48 | 165 | 15 | 601 | |
| Jung Wook Park | 219 | 239 | 35 | 63 | 22 | 584 | |
| Myla Lai-Goldman | 253 | 93 | 42 | 144 | 14 | 467 |
All Works
Loading papers...